| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.17 | 0.003 |